NSD2 and acute lymphoblastic leukemia: Translocations of the NSD methylases: In 15–20% of multiple myeloma patients, a t(4:14) translocation places NSD2 under the control of the strong IGH enhancer (see Table 1), and this translocation is also seen in ALL [60].